$2.430
-0.105 (-4.33%)收盘时
价格预测
在 App 中打开以解锁更长周期的预测。
FATE 相似图表分析预测
Alphio's FATE stock price prediction model matches the current Fate Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $2.43 (+0.01%). The 1-week path is $2.45 (+0.98%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
该买入 Fate Therapeutics Inc 股票吗？
Fate Therapeutics Inc is a good buy right now due to its recent FDA clearance for the FT839 CAR T-cell product, which has the potential to significantly impact autoimmune disease treatment. The current price of $2.43 is well below the analyst price target of $4 from Jefferies and $7 from H.C. Wainwright, indicating substantial upside potential. Additionally, the stock has shown a year-to-date change of +146.35%, reflecting strong investor interest and confidence in its future prospects. However, the main risk is the negative earnings trend, with an EPS of -0.25 reported in the last quarter, which investors should monitor closely.
FATE 股价于 Friday 收于 $2.43，此前下跌 -4.33%
Fate Therapeutics Inc (FATE) last closed at $2.43, losing -4.33%. These facts feed the 1-day and 1-week FATE price prediction above.
分析师一致预期
Fate Therapeutics Inc（FATE）：买入 6、持有 0、卖出 0。展望：Strong Buy。
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
预测驱动因素
Fate Therapeutics Inc（FATE）的预测驱动因素综合了相似的图表形态、季节性与移动平均线。
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bullish
相似图表形态
近期走势与 FATE 最接近的股票，按相似度排序。
FATE 季节性分析
Historically the probability of a positive August return for FATE is 46.03%. February offers the highest probability of a positive month at 67.24%, while October is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
FATE 十年价格预测
| 月份 | 最低价 | 平均价 | 最高价 | 潜在回报率 |
|---|---|---|---|---|
| Aug 2026 | $1.39 | $1.51 | $1.68 | -37.80% |
| Sep 2026 | $1.49 | $1.67 | $1.86 | -31.45% |
| Oct 2026 | $1.06 | $1.28 | $1.42 | -47.31% |
| Nov 2026 | $1.08 | $1.34 | $1.47 | -44.82% |
| Dec 2026 | $1.27 | $1.48 | $1.58 | -38.98% |
2026 年，Fate Therapeutics Inc（FATE）预计区间为 $1.06 至 $1.86。
Fate Therapeutics Inc 2026 年月度预测
2026 年 Aug，Fate Therapeutics Inc 预计均价 $1.51，最低 $1.39，最高 $1.68。
2026 年 Sep，Fate Therapeutics Inc 预计均价 $1.67，最低 $1.49，最高 $1.86。
2026 年 Oct，Fate Therapeutics Inc 预计均价 $1.28，最低 $1.06，最高 $1.42。
2026 年 Nov，Fate Therapeutics Inc 预计均价 $1.34，最低 $1.08，最高 $1.47。
2026 年 Dec，Fate Therapeutics Inc 预计均价 $1.48，最低 $1.27，最高 $1.58。
本页仅供研究参考，不构成投资建议。模型可能出错。过往表现不代表未来结果。